Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-02-02

Clinical Trial Update: INTUPRO in the Treatment of Benign Prostatic Hyperplasia-Related Symptoms [NA]

View source ↗

Summary

INTUPRO is recruiting for a trial to evaluate treatment of benign prostatic hyperplasia-related symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INTUPRO

Snippet

Sponsor: inTumo Therapeutics, Inc. | Conditions: BPH (Benign Prostatic Hyperplasia), BPH | NA | Status: RECRUITING